Form 4 for RCUS Arcus Biosciences, Inc.
Accepted 2024-12-20 00:00:00 ET · period of report 2024-12-19 · accession 0001724521-24-000187 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-20 | 2024-12-19 | RCUS | Azoy Alexander | CAO | D - Sale to Iss | $15.17 | -3,007 | 13.1K | -19% | -$45.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-19 | D | D | 3,007 | $15.17 | 13,094 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2024. |